Akkermansia muciniphila identified as key strain to alleviate gut barrier injury through Wnt signaling pathway
eLife · 2025
DOI: 10.7554/elife.92906 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Xin Ma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Animal Nutrition and Feed Science in East China, Ministry of Agriculture, College of Animal Sciences, Zhejiang University, Hangzhou…. Hauptthemen laut MEDLINE: Wnt Signaling Pathway, Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Intestinal Mucosa. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
As the largest mucosal surface, the gut has built a physical, chemical, microbial, and immune barrier to protect the body against pathogen invasion. The disturbance of gut microbiota aggravates pathogenic bacteria invasion and gut barrier injury. Fecal microbiota transplantation (FMT) is a promising treatment for microbiome-related disorders, where beneficial strain engraftment is a significant factor influencing FMT outcomes. The aim of this research was to explore the effect of FMT on antibiotic-induced microbiome-disordered (AIMD) models infected with enterotoxigenic Escherichia coli (ETEC). We used piglet, mouse, and intestinal organoid models to explore the protective effects and mechanisms of FMT on ETEC infection. The results showed that FMT regulated gut microbiota and enhanced the protection of AIMD piglets against ETEC K88 challenge, as demonstrated by reduced intestinal pathogen colonization and alleviated gut barrier injury. Akkermansia muciniphila ( A. muciniphila ) and Bacteroides fragilis ( B. fragilis ) were identified as two strains that may play key roles in FMT. We further investigated the alleviatory effects of these two strains on ETEC infection in the AIMD mice model, which revealed that A. muciniphila and B. fragilis relieved ETEC-induced intestinal inflammation by maintaining the proportion of Treg/Th17 cells and epithelial damage by moderately activating the Wnt/β-catenin signaling pathway, while the effect of A. muciniphila was better than B. fragilis . We, therefore, identified whether A. muciniphila protected against ETEC infection using basal-out and apical-out intestinal organoid models. A. muciniphila did protect the intestinal stem cells and stimulate the proliferation and differentiation of intestinal epithelium, and the protective effects of A. muciniphila were reversed by Wnt inhibitor. FMT alleviated ETEC-induced gut barrier injury and intestinal inflammation in the AIMD model. A. muciniph ila was identified as a key strain in FMT to promote the proliferation and differentiation of intestinal stem cells by mediating the Wnt/β-catenin signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Animal Nutrition and Feed Science in East China, Ministry of Agriculture, College of Animal Sciences, Zhejiang University, Hangzhou, China.
- Hainan Institute of Zhejiang University, Yongyou Industry Park, Yazhou Bay Sci-Tech City, Sanya, China.
ORCID-Profile: Xinyan Han
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ma, X., Li, M., Zhang, Y., Xu, T., Zhou, X., Qian, M., Yang, Z., & Han, X. (2025). Akkermansia muciniphila identified as key strain to alleviate gut barrier injury through Wnt signaling pathway. eLife. https://doi.org/10.7554/elife.92906
Vancouver
Ma X, Li M, Zhang Y, Xu T, Zhou X, Qian M, et al. Akkermansia muciniphila identified as key strain to alleviate gut barrier injury through Wnt signaling pathway. eLife. 2025. doi:10.7554/elife.92906
BibTeX
@article{Ma2025,
author = {Ma, Xin and Li, Meng and Zhang, Yuanyuan and Xu, Tingting and Zhou, Xinchen and Qian, Mengqi and Yang, Zhiren and Han, Xinyan},
title = {Akkermansia muciniphila identified as key strain to alleviate gut barrier injury through Wnt signaling pathway},
journal = {eLife},
year = {2025},
doi = {10.7554/elife.92906}
}
EUVIMED